Topper James N

CIK 00013413829 companiesFLORHAM PARK,, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001341382

Recent Transactions

50 trades

Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16$16.00/sh+625,000→ 4,552,774 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+3,927,774→ 3,927,774 total
Conversion
MBX Biosciences, Inc.$MBX
Series B Convertible Preferred Stock
2024-09-16−28,297,265→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Series A Convertible Preferred Stock
2024-09-16−18,922,852→ 0 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-05-23+10,500→ 32,096 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2024-05-23−17,500→ 17,500 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−17,500→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition from Tender
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-18−2,829,347→ 0 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-04-25$64.57/sh−19→ 2,829,347 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Warrant (Right to Buy)
2024-04-25−1,200,000→ 0 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-04-25$0.00/sh+1,200,000→ 2,829,366 total
Purchase
HilleVax, Inc.
Common Stock
2024-04-04$14.50/sh+8,850→ 8,544,187 total
Purchase
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2024-03-26$21.50/sh+8,429→ 3,008,429 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-02+17,500→ 17,500 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-05-25+9,000→ 21,596 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2023-05-25+15,000→ 15,000 total
Award
ANAPTYSBIO, INC$ANAB
Director Stock Option (right to buy)
2018-02-02+6,000→ 6,000 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2016-06-16+38,835→ 38,835 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2010-06-15+10,000→ 10,000 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.04/sh+100→ 915,464 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$9.98/sh+200→ 915,364 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.45/sh+13→ 919,996 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.35/sh+30→ 919,599 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.50/sh+368→ 920,664 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.18/sh+160→ 915,924 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.44/sh+70→ 919,983 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.20/sh+1,400→ 917,424 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.22/sh+200→ 917,964 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.36/sh+14→ 919,613 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.19/sh+100→ 916,024 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.21/sh+340→ 917,764 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-10$10.32/sh+5→ 919,569 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$10.08/sh+5,263→ 913,064 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$9.96/sh+1,000→ 897,102 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$9.96/sh+993→ 898,095 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$9.90/sh+192→ 893,210 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$10.14/sh+1,800→ 915,064 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$9.98/sh+501→ 900,986 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$9.94/sh+300→ 895,910 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$10.00/sh+868→ 907,464 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$9.94/sh+800→ 895,610 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$10.12/sh+200→ 913,264 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$9.97/sh+400→ 899,895 total
Purchase
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2008-03-06$9.92/sh+500→ 893,710 total

Companies

Recent Filings

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK,, NJ, 07932

View on SEC.gov